A carregar...
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy
Epithelial ovarian cancer is the sixth most common cancer among women worldwide and the first cause of death among gynecological malignancies. Most of the patients present recurrent disease and unfortunately cannot be cured. The unsatisfactory results obtained with salvage chemotherapy have elicited...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5983012/ https://ncbi.nlm.nih.gov/pubmed/29881257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S124447 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|